With the UAE health authorities granting regulatory approval to Gilead Sciences to use remdesivir in COVID-19 patients, we take a closer look at its role in the recovery process.
In an exclusive interview with Dubai Eye on One, Frederico Silva, General Manager at Gilead for the Middle East region, explains what remdesivir actually does.
He also explained at what stage a COVID-19 patient should be given the drug.
Silva also touched upon the talks Gilead is having with the UAE Ministry of Health.
Talking about the pricing, he explained how Gilead has come up with two approaches - one for less developed countries and the second for developed nations.
Dubai Mallathon passes 100,000 participants in second edition
UAE issues rainfall alert in several areas from Saturday afternoon
Abu Dhabi reopens parks, beaches after weather improvement
UAE, seven nations urge immediate halt to Israel's E1 settlement plan
Abu Dhabi closes parks, beaches due to weather changes
